Rarely, our institutions may test for CDKN2A or BAP1 as a single test, particularly if other cancers, such as pancreatic cancer or astrocytoma in the family, strongly suggest CDKN2A is the offending gene. The gene discussed is BAP1; the disease is pancreatic neoplasm.